ANDA Submissions - Refuse-to-Receive Standards: Questions and Answers Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 3, 2017
April 21, 2020
9263d6de-7354-4678-ba95-003ad712d3c3
Related Documents
Forms FDA 3542a and FDA 3542: Questions and Answers
Guidance DocumentJune 15, 2026Center for Drug Evaluation and Research
Sameness Evaluations in an ANDA — Active Ingredients
Guidance DocumentNovember 8, 2022Center for Drug Evaluation and Research
Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs
Guidance DocumentOctober 21, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.